Sanofi acquires biotech company Tidal Therapeutics for $470m
Sanofi has acquired biotech company Tidal Therapeutics to add an advanced mRNA-based research platform with applications in various disease areas…
Latest Immunology
-
4 days
-
2 weeks
-
2 months
-
2 months
-
4 days
-
2 weeks
-
2 months
-
2 months
Amgen signs agreement to acquire Rodeo Therapeutics for $721m
Amgen has entered an agreement to acquire US-based biopharmaceutical company Rodeo Therapeutics for up to $721m. According to the deal,…
Latest News
View More
Sanofi signs agreement to acquire Kiadis Pharma for $359m
Sanofi has signed a definitive agreement to acquire the entire share capital of Kiadis Pharma in a deal valued at approximately €308m ($359m). Under the…
STADA agrees to buy 15 consumer healthcare brands from GSK
Germany-based STADA has agreed to buy a portfolio of 15 consumer healthcare brands from GlaxoSmithKline (GSK) in European countries, including Germany, France, Poland, Italy, Russia,…
Takeda’s SC Entyvio meets primary endpoint in Crohn’s Disease
At the European Crohn’s and Colitis Organization (ECCO) congress in Vienna, Austria, Takeda announced the subcutaneous (SC) formulation of Entyvio…
Horizon Therapeutics gets FDA approval for thyroid eye disease drug
Irish pharmaceutical company Horizon Therapeutics has received the US Food and Drug Administration (FDA) approval for Tepezza (teprotumumab-trbw) to treat…
Amneal licenses myasthenia gravis drug from Kashiv BioSciences
Amneal Pharmaceuticals has signed an agreement with Kashiv BioSciences to license orphan drug K127 (pyridostigmine) to treat myasthenia gravis. Myasthenia…
Gilead and Glympse partner in clinical development for NASH
Gilead has announced it will be leveraging Glympse Bio’s synthetic biomarker technology to support its nonalcoholic steatohepatitis (NASH) clinical development…
Company A-Z
View More
Rheo Engineering
Material Handling Products and Turnkey Process Systems for Pharmaceutical Applications
Latest Content
View More
Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19
Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates Follow the updates on coronavirus (COVID-19): Countries affected…
Bi-specific antibodies as keys to augment the effects of immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have provided an unprecedented duration of response and disease-free survival outcomes in cancer therapy, a feat…
Fujifilm Diosynth Biotechnologies’ Biologics Production Facility Expansion
Fujifilm Diosynth Biotechnologies (FDB), a subsidiary of Japanese multinational conglomerate Fujifilm, is expanding its large-scale biologics production facility in Hillerod,…
DIOSNA Fluid Bed Processor – Flexible Small Scale Lab Solution
Targeted development processes and a variety of products set high standards in the reliability, control and security of the processes.…
Freeze-Thaw Units for the Pharmaceutical Industry
Reliable process control is indispensable when freezing and thawing pharmaceutical and biotechnological products. The same applies to the adjustable freezing…